Pleo Luffa Tablets 4X
Natural health product licensed in Canada
- Other names
- Luffasan D4 Tabletten
- Licence holder
- Sanum-Kehlbeck GmbH & Co. KG
- NPN or DIN-HM
- 80124093
- Status
- Active licence
- Licence date
- 27 April 2023
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Fécule de pomme de terre, Lactose monohydraté
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants, adolescents et adultes | minimum: 6 years | minimum: 1 Comprimé ; maximum: 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Homeopathic preparation/remedy/medicine.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80124093
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.